November 26–28 | Shanghai Dr. Feng Ren, Co-CEO and Chief Scientific Officer of Insilico Medicine, has been invited to attend the 6th Annual Meeting of the Chinese Society for Cell and Gene Therapy in Shanghai. (IMAGE)
Caption
On November 26 at 15:00, he will speak at Track 1: Omics and AI Frontiers for Cell and Gene Therapy, delivering a keynote presentation titled "From Technological Breakthrough to Clinical Validation: The Second Half of AI-Driven Drug Discovery".
Credit
Insilico Medicine
Usage Restrictions
None
License
Original content